Evidence map›Paper›PMID 41209016›Full record

ArticleFrontiers in immunology2025

Assessment of antigen-specific T cell recall responses in non-human primates using a composite AIM assay.

Jan M Schmidt, Mayuri Prasad, Kenna Degner, Rebecca Schiavo, Allison Repic, Lauren Little, Laura Israel, Feng Chen, Regine Hansen, Anette C Karle and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jan M SchmidtNovartis Biomedical Research, Preclinical Safety, Basel, Switzerland.
Mayuri PrasadLabCorp, Early Development Laboratories, Madison, WI, United States.
Kenna DegnerLabCorp, Early Development Laboratories, Madison, WI, United States.
Rebecca SchiavoLabCorp, Early Development Laboratories, Madison, WI, United States.
Allison RepicLabCorp, Early Development Laboratories, Madison, WI, United States.
Lauren LittleLabCorp, Early Development Laboratories, Madison, WI, United States.
Laura IsraelNovartis Biomedical Research, Biologics Research Center, Basel, Switzerland.
Feng ChenNovartis Biomedical Research, DAx, Cambridge MA, United States.
Regine HansenNovartis Biomedical Research, Preclinical Safety, Basel, Switzerland.
Anette C KarleNovartis Biomedical Research, Biologics Research Center, Basel, Switzerland.
Kees LeenhoutsAllero Therapeutics, Rotterdam, Netherlands.
Poul SørensenAllero Therapeutics, Rotterdam, Netherlands.
Brian McIntoshLabCorp, Early Development Laboratories, Madison, WI, United States.
Dominique BreesNovartis Biomedical Research, Preclinical Safety, Basel, Switzerland.
José M CarballidoNovartis Biomedical Research, Preclinical Safety, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Characterizing antigen-specific T cell responses is essential for understanding the immunogenicity of biotherapeutics and mitigating drug-specific immune reactions. Methods: This study describes a flow cytometry composite Activation-Induced Marker (cAIM) assay for cynomolgus monkeys that allows quantification of T cell recall responses to multiple antigens using up to ten AIM pairs. The procedure incorporates two composite metrics (cAIM-index and cAIM-score) that facilitate the summation of T cell recall responses into interpretable numeric values, reducing reliance on multiple graphical comparisons. The assay is compatible with human and mouse samples and can utilize peripheral blood mononuclear cells or whole blood. Additionally, the method is well suited for the mass cytometry platform, enabling the detection of antigen-specific CD4 Results: The assay successfully enables quantification of antigen-specific T cell recall responses across multiple antigens and species, while composite metrics streamline interpretation. Discussion: These protocols shall support preclinical and clinical immunogenicity assessments, advancing biotherapeutic development.

Indexed as

AntigensCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFlow CytometryImmunologic MemoryT-LymphocytesAnimalsHumansImmunophenotypingLymphocyte ActivationMacaca fascicularisAntigensactivation-induced marker assayantigen-specific T cell recall responsesbiotherapeutic developmentfluorescent and mass cytometryimmunogenicity assessmentsnon-human primates

Identifiers

PMID41209016
PMCPMC12592150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.